Related Experiment Video
Updated: Dec 7, 2025

05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.0K
Prodrugs: My Initial Exploration and Where It Led.
1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047, USA.
Journal of Pharmaceutical Sciences
|October 1, 2020
Summary
This review explores prodrugs, focusing on phenytoin (diphenylhydantoin) prodrugs. Prodrug strategies are vital for developing challenging small molecule drugs.
Area of Science:
- Medicinal Chemistry
- Drug Development
- Pharmacology
Background:
- Prodrugs are modified drug forms enhancing delivery or efficacy.
- Phenytoin (diphenylhydantoin) is a key anticonvulsant drug.
- Developing challenging small molecules often requires prodrug approaches.
Purpose of the Study:
- To review the early exploration of prodrugs.
- To specifically examine prodrugs of the anticonvulsant phenytoin.
- To provide insights into the utility of prodrug intervention.
Main Methods:
- Literature review of prodrug strategies.
- Focus on prodrug design for phenytoin.
- Historical perspective on prodrug development.
Main Results:
- Prodrugs offer a valuable tool for drug development.
- Prodrugs can transform un-developable drugs into viable therapeutics.
- The exploration highlights the significance of prodrug interventions.
Conclusions:
- Prodrugs are essential for overcoming challenges in small molecule drug development.
- Phenytoin prodrugs represent a significant area of research.
- Prodrug strategies continue to be a critical aspect of pharmaceutical science.
Related Concept Videos
Drug Discovery: Overview
10.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K
Prodrugs
3.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
3.6K
Preclinical Development: Overview
5.6K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
Clinical Trials: Overview
4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Drug Administration and Therapy Phases: Overview
1.0K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.0K
Structure-Activity Relationships and Drug Design
1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K

